We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YEXT:NYSEYext, Inc. Analysis

Data as of 2026-09-01 - not real-time

$6.77

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Yext, Inc. is neutral at $6.77, with no clear ordering between short and long averages. Over a rolling month the price has gained 26.8%. Relative strength is 73.9 — overbought — and the MACD signal is bullish. Recent trading has carved out support near $5.49 and resistance around $6.92.
Valuation screens as overvalued: a P/E of 84.6 sits above the sector average of 35.8. Sell-side targets cluster 26.1% below the current quote.
The composite risk read is 8/10, putting it in high territory. With 30-day volatility of 50.8%, a beta of 0.71 and a maximum drawdown of 63.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.

Top Market Events

Yext Inc. NYSE:YEXT is one of the best value penny stocks to buy according to hedge funds. On June 2, Yext reported its...NEW YORK, July 07, 2026--Yext, Inc. NYSE: YEXT , the enterprise agentic marketing platform, today announced that it has...NEW YORK, July 07, 2026--Yext, Inc. NYSE: YEXT , the enterprise agentic marketing platform, today announced that it has...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • RSI at 73.9 signals overbought conditions
  • Trading above the 200-day average of 5.70
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • RSI at 73.9 signals overbought conditions
  • P/E of 84.6 versus sector average of 35.8
  • Trading above the 200-day average of 5.70

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 84.6 versus sector average of 35.8
  • Analyst targets imply -26.1% versus the current price
  • Revenue contracting at -1.4%

Key Metrics & Analysis

Financial Health

Revenue Growth-1.40%
Profit Margin8.93%
P/E Ratio84.6
ROE47.72%
ROA0.72%
Debt/Equity917.94
P/B Ratio5.2
Op. Cash Flow$55.6M
Free Cash Flow$29.2M
Industry P/E35.8

Technical Analysis

TrendNeutral
RSI73.9
Support$5.49
Resistance$6.92
MA 20$6.08
MA 50$5.41
MA 200$5.70
MACDBullish
VolumeStable
Fear & Greed Index94.79

Valuation

Fair Value$2.39
Target Price$5.00
Upside/Downside-26.14%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.71
Volatility50.82%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.